BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1274 related articles for article (PubMed ID: 17009270)

  • 21. Short-term efficacy of intravenous pulse glucocorticoids in acute discogenic sciatica. A randomized controlled trial.
    Finckh A; Zufferey P; Schurch MA; Balagué F; Waldburger M; So AK
    Spine (Phila Pa 1976); 2006 Feb; 31(4):377-81. PubMed ID: 16481946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis.
    Gonzalez-Juanatey C; Llorca J; Garcia-Porrua C; Sanchez-Andrade A; Martín J; Gonzalez-Gay MA
    J Rheumatol; 2006 Jan; 33(1):74-8. PubMed ID: 16395753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
    Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
    J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
    Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA
    Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.
    Gross V; Andus T; Caesar I; Bischoff SC; Lochs H; Tromm A; Schulz HJ; Bär U; Weber A; Gierend M; Ewe K; Schölmerich J
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):905-9. PubMed ID: 8889459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al.
    Bertoli AM; Font YM; Nadal A; Vilá LM
    Arthritis Rheum; 2007 May; 56(5):1723; author reply 1723-4. PubMed ID: 17469171
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
    N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
    Hoffman GS; Merkel PA; Brasington RD; Lenschow DJ; Liang P
    Arthritis Rheum; 2004 Jul; 50(7):2296-304. PubMed ID: 15248230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
    Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
    Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
    Tseng CE; Buyon JP; Kim M; Belmont HM; Mackay M; Diamond B; Marder G; Rosenthal P; Haines K; Ilie V; Abramson SB
    Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.
    Weyand CM; Fulbright JW; Hunder GG; Evans JM; Goronzy JJ
    Arthritis Rheum; 2000 May; 43(5):1041-8. PubMed ID: 10817557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G; Pestronk A; Al-Lozi M
    Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies.
    van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
    Arthritis Rheum; 2004 Apr; 51(2):233-8. PubMed ID: 15077265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trial of Tocilizumab in Giant-Cell Arteritis.
    Stone JH; Tuckwell K; Dimonaco S; Klearman M; Aringer M; Blockmans D; Brouwer E; Cid MC; Dasgupta B; Rech J; Salvarani C; Schett G; Schulze-Koops H; Spiera R; Unizony SH; Collinson N
    N Engl J Med; 2017 Jul; 377(4):317-328. PubMed ID: 28745999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
    Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
    Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical and histopathological effects of prednisone on acute radiation-induced dermatitis in dogs: a placebo-controlled, randomized, double-blind, prospective clinical trial.
    Flynn AK; Lurie DM; Ward J; Lewis DT; Marsella R
    Vet Dermatol; 2007 Aug; 18(4):217-26. PubMed ID: 17610486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
    Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
    Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.